India Business Excellence Fund III
Tracked across 2 events · 23 articles · First seen Aug 05, 2026 · Last active Aug 19, 2026
Live sentiment trends, attention charts, and prominence tracking available on the
Ergen Dashboard
Business
Symbiotec Pharmalab, an Indore-based pharmaceutical and biotechnology company, is launching its initial public offering (IPO) on August 24, 2026, with a price band of Rs 938-988 per share. The IPO aims to raise Rs 1,757…
Impact: The fund is selling shares worth Rs 475 crore in the OFS, partially exiting its investment.
Aug 19, 2026 · 8 articles
Business
Molbio Diagnostics Ltd, a Goa-based point-of-care molecular diagnostics company, has fixed a price band of Rs 768-807 per share for its initial public offering (IPO). The issue, valued at approximately Rs 930-940 crore, comprises a…
Impact: India Business Excellence Fund III, managed by Motilal Oswal, is selling shares in the OFS, reducing its stake. This provides liquidity and potential returns.
Aug 05, 2026 · 15 articles
75
India Business Excellence Fund III offered sharesSymbiotec Pharmalab IPO launch
60
India Business Excellence Fund III sold sharesMolbio Diagnostics IPO...
ERGEN INTELLIGENCE
Track India Business Excellence Fund III live
Set up alerts, explore relationships, view sentiment trends, and monitor how events impact this entity in real time.
Open Dashboard